[144] PROLOGIS, INC. SEC Filing

Rhea-AI Filing Summary

Prologis, Inc. (PLD) filed a Form 144 reporting a proposed sale of 2,621 shares of common stock through Morgan Stanley Smith Barney LLC on 09/03/2025. The filing shows an aggregate market value of $291,717.30 and lists total shares outstanding as 928,063,000. The shares were acquired as restricted stock units on 05/01/2020, and no cash payment details apply. The filer represents they are not aware of any undisclosed material adverse information and provides the standard Rule 144/10b5-1 attestations.

Insights

Securities Analyst

TL;DR: Small insider sale disclosed under Rule 144; likely routine vesting and sale of RSUs, not clearly material to shareholders.

The notice reports a proposed sale of 2,621 shares valued at $291,717.30, executed through Morgan Stanley Smith Barney LLC on 09/03/2025. The shares originated from restricted stock units granted on 05/01/2020. Compared with the issuer's stated outstanding share count of 928,063,000, the position represented is de minimis in scale. The filing includes the required representation about absence of undisclosed material information, consistent with compliance practice for Rule 144 sales and potential 10b5-1 plans.

Corporate Governance Expert

TL;DR: Filing meets disclosure norms; it documents insider compliance with transfer rules and attestation obligations.

The Form 144 provides the broker, security class, acquisition origin (RSUs), acquisition date, and planned sale date, fulfilling statutory disclosure elements. The attestation that no material nonpublic information is known by the seller aligns with Rule 144 and typical governance controls. There is no indication of unusual trading patterns or coordinated large disposals in this notice.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2621	291717.30	928063000	09/03/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/01/2020	Restricted Stock Units	Issuer			2621	05/01/2020	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did Prologis (PLD) report on the Form 144?

The filing reports a proposed sale of 2,621 common shares through Morgan Stanley Smith Barney LLC on 09/03/2025 with an aggregate market value of $291,717.30.

How were the shares being sold acquired?

The shares were acquired as restricted stock units (RSUs) on 05/01/2020 from the issuer.

What is the issuer's total shares outstanding according to the filing?

The filing lists 928,063,000 shares outstanding.

Does the filing indicate any undisclosed material information?

The filer represents by signature that they do not know of any material adverse information about the issuer that has not been publicly disclosed.

Did the filer report other securities sold in the past three months?

The filing states "Nothing to Report" for securities sold during the past three months.